A team of class action attorneys and personal injury lawyers has launched an investigation into proton pump inhibitor (ppi) medications used to treat heartburn, antacid, acid reflux, stomach acid, gastric, peptic or duodenal stomach ulcers, damaged esophagus, gastroesophageal reflux disease (gerd), esophagitis, barrett’s esophagus, zollinger. Class action lawsuit acid reflux medication. A common type of heartburn medication called proton pump inhibitors (ppis) seem to be linked with increased risk of chronic kidney disease, two new studies suggest prilosec, nexium and prevacid belong to this class of drugs, which treat heartburn and acid reflux by lowering the amount of acid produced by the stomach.
class action lawsuit acid reflux medication
Astrazeneca class action lawsuit in 2015, astrazeneca settled a class action lawsuit that involved prilosec and nexium consumers claimed that the drug company was trying to boost sales of nexium as their patent for prilosec ran out chemically, the drugs are nearly identical, but nexium was much more expensive. Update: ppi acid reflux drugs increase stomach cancer risk by up to 250%, study finds. december 1, 2017 – extended use of ppis (3 years or more) can elevate your risk of stomach cancer by up to 250%, a new study has found. for short-term treatment, the drugs have proved safe for blockinh stomach acid production.. The lawsuit also alleges the medication caused him to suffer a number of serious health issues. another patient in the state is looking to pursue legal action after taking zantac at the age of 15 for acid reflux and developing breast cancer. these lawsuits make similar allegations against sanofi, including:.
0 comments:
Post a Comment